The company is constantly evaluating important indications where cariprazine can be of benefit in the treatment of patients. At the moment, however, the only approved indication for cariprazine in the EU is treatment of schizophrenia.
The company is constantly evaluating important indications where cariprazine can be of benefit in the treatment of patients. At the moment, however, the only approved indication for cariprazine in the EU is treatment of schizophrenia.